Viking Global Investors LP
Major shareholder at Inhibrx Biosciences · 4 reported transactions in 2 companies · latest trade Oct 7, 2025
Their trades
Sold | Oct 7, 2025 | Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days. | ||
Sold | Oct 7, 2025 | Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days. | ||
Sold | Oct 7, 2025 | Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days. | ||
Sold | Jun 27, 2025 | Jun 27, 2025 close $44.86 → Oct 29, 2026 close $70.73. S&P 500 +25.6% over the same days. |
$807.6K
Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days.
$526.2K
Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days.
$9.95M
Oct 7, 2025 close $33.50 → Oct 29, 2026 close $73.65. S&P 500 +15.4% over the same days.
SoldBridgebio Pharma
$154M
Jun 27, 2025 close $44.86 → Oct 29, 2026 close $70.73. S&P 500 +25.6% over the same days.